Home> Products> affordable cholesterol management steris healthcare

{ "products": [ { "_id": "666ac1c8d0d0330684bdbc69", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NICOMALOM 4 ", "description": "NICOMALOM 4 \nNicoumalone (4mg)\nIntroduction:\n\nNICOMALOM 4 contains Nicoumalone (4 mg), a potent anticoagulant medication used to prevent and treat thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation. Nicoumalone works by inhibiting the synthesis of vitamin K-dependent clotting factors, thereby reducing blood clot formation.\nKey Features and Benefits:\n\nThromboembolism Prevention: Nicoumalone effectively reduces the risk of blood clot formation, helping to prevent conditions like DVT and PE.\nStroke Risk Reduction: It is beneficial for patients with atrial fibrillation, reducing the risk of stroke by preventing clot formation in the heart.\nLong-Term Management: Nicoumalone is suitable for long-term use in patients with chronic conditions that predispose them to thromboembolic events.\nStandardized Dosing: The 4 mg dosage allows for precise adjustments based on the patient's prothrombin time (PT) and International Normalized Ratio (INR) levels, ensuring optimal anticoagulation.\nCost-Effective: As an established anticoagulant, Nicoumalone offers an affordable option for long-term management of thromboembolic disorders.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of NICOMALOM 4 is determined based on the patient's INR, with adjustments made according to regular blood tests. The initial dose may vary, but careful monitoring is essential.\nMaintenance Dosage: The maintenance dose is individualized based on the target INR range, usually between 2.0 and 3.0 for most indications. Doses are adjusted by a healthcare provider based on regular INR monitoring.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Nicoumalone at the same time each day to maintain consistent blood levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/nicomalom-4-133593", "price": 389.4, "discountamount": 116.82, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "heart", "water", "Doses", "EMAIL", "tablet", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "Nicoumalone", "4 mg dosage", "INR) levels", "information", "Introduction", "Key Features", "sterisonline", "initial dose", "sterispharma", "long-term use", "CALL/WHATSAPP", "Administration", "Initial Dosage", "target INR range", "prothrombin time", "most indications", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1862, "imageuri": "https://productimages.withfloats.com/actual/667d22cdba7e6420d2a5125f.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d22cdba7e6420d2a5125f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:54:16.529Z", "updatedon": "2024-06-27T08:29:00.414Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nicomalom-4-/1862", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 4 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 4 mg tablet price", "nicoumalone 4mg", "nicoumalone 1mg uses in hindi", "acitrom 4mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666abf93396cee0250f91bbf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NICOMALOM 3 ", "description": "NICOMALOM 3 \nNicoumalone (3mg)\nIntroduction:\n\nNICOMALOM 3 contains Nicoumalone (3 mg), a potent anticoagulant medication used to prevent and treat thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation. Nicoumalone works by inhibiting the synthesis of vitamin K-dependent clotting factors, thereby reducing blood clot formation.\nKey Features and Benefits:\n\nThromboembolism Prevention: Nicoumalone effectively reduces the risk of blood clot formation, helping to prevent conditions like DVT and PE.\nStroke Risk Reduction: It is beneficial for patients with atrial fibrillation, reducing the risk of stroke by preventing clot formation in the heart.\nLong-Term Management: Nicoumalone is suitable for long-term use in patients with chronic conditions that predispose them to thromboembolic events.\nStandardized Dosing: The 3 mg dosage allows for precise adjustments based on the patient's prothrombin time (PT) and International Normalized Ratio (INR) levels, ensuring optimal anticoagulation.\nCost-Effective: As an established anticoagulant, Nicoumalone offers an affordable option for long-term management of thromboembolic disorders.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of NICOMALOM 3 is determined based on the patient's INR, with adjustments made according to regular blood tests. The initial dose may vary, but careful monitoring is essential.\nMaintenance Dosage: The maintenance dose is individualized based on the target INR range, usually between 2.0 and 3.0 for most indications. Doses are adjusted by a healthcare provider based on regular INR monitoring.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Nicoumalone at the same time each day to maintain consistent blood levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/nicomalom-3-133592", "price": 359.4, "discountamount": 107.82, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "EMAIL", "water", "Doses", "heart", "tablet", "product", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "3 mg dosage", "information", "INR) levels", "Nicoumalone", "initial dose", "sterisonline", "Key Features", "sterispharma", "Introduction", "CALL/WHATSAPP", "long-term use", "Initial Dosage", "Administration", "prothrombin time", "most indications", "target INR range", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1861, "imageuri": "https://productimages.withfloats.com/actual/666abf968b71a2cb2d7d4e2d.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666abf968b71a2cb2d7d4e2d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:44:51.78Z", "updatedon": "2024-06-26T11:15:50.58Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nicomalom-3-/1861", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 3 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 3mg uses", "nicoumalone side effects", "nicoumalone tablet uses in hindi", "nicoumalone contraindications", "nicoumalone tablet price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666abe06cee93a1bbc383645", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NICOMALOM 2 ", "description": "NICOMALOM 2 \nNicoumalone (2mg)\nIntroduction:\n\nNICOMALOM 2 contains Nicoumalone (2 mg), a potent anticoagulant medication used to prevent and treat thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation. Nicoumalone works by inhibiting the synthesis of vitamin K-dependent clotting factors, thereby reducing blood clot formation.\nKey Features and Benefits:\n\nThromboembolism Prevention: Nicoumalone effectively reduces the risk of blood clot formation, helping to prevent conditions like DVT and PE.\nStroke Risk Reduction: It is beneficial for patients with atrial fibrillation, reducing the risk of stroke by preventing clot formation in the heart.\nLong-Term Management: Nicoumalone is suitable for long-term use in patients with chronic conditions that predispose them to thromboembolic events.\nStandardized Dosing: The 2 mg dosage allows for precise adjustments based on the patient's prothrombin time (PT) and International Normalized Ratio (INR) levels, ensuring optimal anticoagulation.\nCost-Effective: As an established anticoagulant, Nicoumalone offers an affordable option for long-term management of thromboembolic disorders.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of NICOMALOM 2 is determined based on the patient's INR, with adjustments made according to regular blood tests. The initial dose may vary, but careful monitoring is essential.\nMaintenance Dosage: The maintenance dose is individualized based on the target INR range, usually between 2.0 and 3.0 for most indications. Doses are adjusted by a healthcare provider based on regular INR monitoring.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Nicoumalone at the same time each day to maintain consistent blood levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/nicomalom-2-133591", "price": 243.0, "discountamount": 72.9, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "heart", "water", "Doses", "EMAIL", "tablet", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "Nicoumalone", "2 mg dosage", "INR) levels", "information", "Introduction", "Key Features", "sterisonline", "initial dose", "sterispharma", "long-term use", "CALL/WHATSAPP", "Administration", "Initial Dosage", "target INR range", "prothrombin time", "most indications", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1860, "imageuri": "https://productimages.withfloats.com/actual/666abe098b71a2cb2d7d3c68.png", "tileimageuri": "https://productimages.withfloats.com/tile/666abe098b71a2cb2d7d3c68.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:38:14.673Z", "updatedon": "2024-06-26T11:13:41.928Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nicomalom-2-/1860", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 2 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 2mg uses", "nicoumalone tablet", "nicoumalone tablets side effects", "nicoumalone tablet dosage", "nicoumalone drug interactions" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666abcb0f7438b1754ba0c31", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NICOMALOM 1 ", "description": "NICOMALOM 1 \nNicoumalone (1mg)\nIntroduction:\n\nNICOMALOM 1 contains Nicoumalone (1 mg), an anticoagulant medication used to prevent and treat thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation. Nicoumalone works by inhibiting the synthesis of vitamin K-dependent clotting factors, thereby reducing blood clot formation.\nKey Features and Benefits:\n\nThromboembolism Prevention: Nicoumalone effectively reduces the risk of blood clot formation, helping to prevent conditions like DVT and PE.\nStroke Risk Reduction: It is beneficial for patients with atrial fibrillation, reducing the risk of stroke by preventing clot formation in the heart.\nLong-Term Management: Nicoumalone is suitable for long-term use in patients with chronic conditions that predispose them to thromboembolic events.\nStandardized Dosing: The 1 mg dosage allows for precise adjustments based on the patient's prothrombin time (PT) and International Normalized Ratio (INR) levels, ensuring optimal anticoagulation.\nCost-Effective: As an established anticoagulant, Nicoumalone offers an affordable option for long-term management of thromboembolic disorders.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of NICOMALOM 1 is determined based on the patient's INR, with adjustments made according to regular blood tests. The initial dose may vary, but careful monitoring is essential.\nMaintenance Dosage: The maintenance dose is individualized based on the target INR range, usually between 2.0 and 3.0 for most indications. Doses are adjusted by a healthcare provider based on regular INR monitoring.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Nicoumalone at the same time each day to maintain consistent blood levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/nicomalom-1-133590", "price": 183.0, "discountamount": 54.9, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "Doses", "heart", "EMAIL", "water", "tablet", "product", "Benefits", "patients", "NICOMALOM", "same time", "synthesis", "Nicoumalone", "INR) levels", "1 mg dosage", "information", "Introduction", "initial dose", "sterispharma", "Key Features", "sterisonline", "long-term use", "CALL/WHATSAPP", "Administration", "Initial Dosage", "most indications", "target INR range", "prothrombin time", "maintenance dose", "affordable option", "Maintenance Dosage", "careful monitoring", "chronic conditions", "pulmonary embolism", "healthcare provider", "atrial fibrillation", "regular blood tests", "Standardized Dosing", "precise adjustments", "Long-Term Management", "deep vein thrombosis", "blood clot formation", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "optimal anticoagulation", "consistent blood levels", "thromboembolic disorders", "anticoagulant medication", "Thromboembolism Prevention", "International Normalized Ratio", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1859, "imageuri": "https://productimages.withfloats.com/actual/666abcb4f068be46bdeaf907.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666abcb4f068be46bdeaf907.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:32:32.095Z", "updatedon": "2024-06-26T11:06:41.45Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nicomalom-1-/1859", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 1 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone tablet 1mg", "nicoumalone 1mg uses in hindi", "nicoumalone 1mg price", "", "nicoumalone class of drug", "acenocoumarol drug interactions" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666185c2161afa2274ff4d10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET GP 2 ", "description": "SEIZMET GP 2 \nGlimepiride (2mg), Metformin SR (500mg), Pioglitazone (15mg)\nIntroduction to SEIZMET GP 2\nSEIZMET GP 2 is a combination medication that includes Glimepiride 2mg, Metformin Hydrochloride Sustained Release (SR) 500mg, and Pioglitazone 15mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Glimepiride, Metformin, and Pioglitazone, SEIZMET GP 2 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Glimepiride, Metformin, and Pioglitazone?\nOverview of Glimepiride\nGlimepiride is a sulfonylurea that helps control blood sugar levels by stimulating the pancreas to release more insulin. It works by closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to insulin secretion.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nOverview of Pioglitazone\nPioglitazone is a thiazolidinedione (TZD) that helps improve blood sugar control by increasing the body's sensitivity to insulin. It works by activating PPARγ (peroxisome proliferator-activated receptor gamma) receptors, which regulate the transcription of insulin-responsive genes involved in the control of glucose and lipid metabolism.\n\nBenefits of SEIZMET GP 2\nEffective Blood Sugar Management\nTriple Mechanism of Action: Glimepiride stimulates insulin secretion, Metformin improves insulin sensitivity and reduces hepatic glucose production, and Pioglitazone enhances insulin sensitivity in peripheral tissues, providing a comprehensive approach to glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET GP 2 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET GP 2 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLipid Profile Improvement: Pioglitazone can improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, offering additional cardiovascular benefits.\nHow to Use SEIZMET GP 2\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET GP 2 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin and Pioglitazone. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET GP 2 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/seizmet-gp-2-133443", "price": 145.5, "discountamount": 43.65, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "TZD", "body", "meal", "Diet", "Order", "EMAIL", "liver", "PPARγ", "water", "amount", "Action", "option", "Support", "pancreas", "Overview", "readings", "biguanide", "overweight", "one tablet", "Guidelines", "neuropathy", "full glass", "retinopathy", "utilization", "information", "Optimal Use", "Adjustments", "Introduction", "best results", "SEIZMET GP 2", "Pioglitazone", "Metformin SR", "sterisonline", "Reduced Risk", "Postprandial", "instructions", "sterispharma", "sulfonylurea", "triglycerides", "effectiveness", "CALL/WHATSAPP", "transcription", "Administration", "obese patients", "typical dosage", "lipid profiles", "treatment plan", "Consistent Use", "Glimepiride 2mg", "lipid metabolism", "Exercise Adjunct", "prolonged effect", "Triple Mechanism", "weight neutrality", "thiazolidinedione", "excellent adjunct", "Weight Management", "insulin secretion", "peripheral tissues", "modest weight loss", "Recommended Dosage", "healthcare provider", "individual response", "blood sugar control", "insulin sensitivity", "Diabetes Management", "pancreatic beta cells", "HDL cholesterol levels", "combination medication", "cardiovascular disease", "comprehensive approach", "Fasting Glucose Control", "long-term complications", "lifestyle modifications", "complementary mechanisms", "insulin-responsive genes", "type 2 diabetes mellitus", "Lipid Profile Improvement", "peripheral glucose uptake", "stable blood sugar levels", "hepatic glucose production", "Additional Health Benefits", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "ATP-sensitive potassium channels", "Effective Blood Sugar Management", "additional cardiovascular benefits", "Metformin Hydrochloride Sustained Release", "peroxisome proliferator-activated receptor gamma) receptors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1443, "imageuri": "https://productimages.withfloats.com/actual/666185c5c06ee12d88cfaefd.png", "tileimageuri": "https://productimages.withfloats.com/tile/666185c5c06ee12d88cfaefd.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T09:47:46.414Z", "updatedon": "2024-06-29T09:07:17.281Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/seizmet-gp-2-/1443", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET GP 2 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET GP 2", "Glimepiride (2mg)", "Metformin SR (500mg)", "Pioglitazone (15mg)", "Pioglitazone side effects", "Pioglitazone 15 mg price", "Side effects of pioglitazone 15 mg", "Is pioglitazone safe", "Pioglitazone uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66618121a743fd2358220c35", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET GP 1 ", "description": "SEIZMET GP 1 \nGlimepiride (1mg), Metformin SR (500mg), Pioglitazone (15mg)\nIntroduction to SEIZMET GP 1\nSEIZMET GP 1 is a combination medication that includes Glimepiride 1mg, Metformin Hydrochloride Sustained Release (SR) 500mg, and Pioglitazone 15mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Glimepiride, Metformin, and Pioglitazone, SEIZMET GP 1 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Glimepiride, Metformin, and Pioglitazone?\nOverview of Glimepiride\nGlimepiride is a sulfonylurea that helps control blood sugar levels by stimulating the pancreas to release more insulin. It works by closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to insulin secretion.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nOverview of Pioglitazone\nPioglitazone is a thiazolidinedione (TZD) that helps improve blood sugar control by increasing the body's sensitivity to insulin. It works by activating PPARγ (peroxisome proliferator-activated receptor gamma) receptors, which regulate the transcription of insulin-responsive genes involved in the control of glucose and lipid metabolism.\n\nBenefits of SEIZMET GP 1\nEffective Blood Sugar Management\nTriple Mechanism of Action: Glimepiride stimulates insulin secretion, Metformin improves insulin sensitivity and reduces hepatic glucose production, and Pioglitazone enhances insulin sensitivity in peripheral tissues, providing a comprehensive approach to glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET GP 1 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET GP 1 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLipid Profile Improvement: Pioglitazone can improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, offering additional cardiovascular benefits.\nHow to Use SEIZMET GP 1\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET GP 1 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin and Pioglitazone. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET GP 1 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/seizmet-gp-1-133442", "price": 144.45, "discountamount": 43.34, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "TZD", "body", "Diet", "Order", "EMAIL", "liver", "PPARγ", "water", "meals", "amount", "Action", "option", "Support", "pancreas", "Overview", "readings", "biguanide", "neuropathy", "one tablet", "full glass", "Guidelines", "overweight", "Optimal Use", "information", "utilization", "Adjustments", "retinopathy", "Metformin SR", "SEIZMET GP 1", "best results", "Pioglitazone", "Introduction", "sterisonline", "Reduced Risk", "Postprandial", "instructions", "sterispharma", "sulfonylurea", "triglycerides", "effectiveness", "CALL/WHATSAPP", "transcription", "Administration", "obese patients", "typical dosage", "lipid profiles", "treatment plan", "Consistent Use", "Glimepiride 1mg", "lipid metabolism", "Exercise Adjunct", "prolonged effect", "Triple Mechanism", "weight neutrality", "thiazolidinedione", "excellent adjunct", "Weight Management", "insulin secretion", "peripheral tissues", "modest weight loss", "Recommended Dosage", "healthcare provider", "individual response", "blood sugar control", "insulin sensitivity", "Diabetes Management", "pancreatic beta cells", "HDL cholesterol levels", "combination medication", "cardiovascular disease", "comprehensive approach", "Fasting Glucose Control", "long-term complications", "lifestyle modifications", "complementary mechanisms", "insulin-responsive genes", "type 2 diabetes mellitus", "Lipid Profile Improvement", "peripheral glucose uptake", "stable blood sugar levels", "hepatic glucose production", "Additional Health Benefits", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "ATP-sensitive potassium channels", "Effective Blood Sugar Management", "additional cardiovascular benefits", "Metformin Hydrochloride Sustained Release", "peroxisome proliferator-activated receptor gamma) receptors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1440, "imageuri": "https://productimages.withfloats.com/actual/66618124c40ee9be019ac7b4.png", "tileimageuri": "https://productimages.withfloats.com/tile/66618124c40ee9be019ac7b4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T09:28:01.365Z", "updatedon": "2024-06-29T09:12:11.939Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/seizmet-gp-1-/1440", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET GP 1 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET GP 1", "Glimepiride (1mg)", "Metformin SR (500mg)", "Pioglitazone (15mg)", "Pioglitazone side effects", "Pioglitazone 15 mg price", "Pioglitazone uses", "Pioglitazone 30 mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66616218a743fd235822082f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIOSTERIS M 500 ", "description": "PIOSTERIS M 500 \nPioglitazone & Metformin Sustained Release Tablet\nIntroduction to PIOSTERIS M 500\nPIOSTERIS M 500 is a combination medication that includes Pioglitazone and Metformin Hydrochloride (Sustained Release). This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Pioglitazone and Metformin, PIOSTERIS M 500 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Pioglitazone and Metformin?\nOverview of Pioglitazone\nPioglitazone is a thiazolidinedione (TZD) that works by increasing the body's sensitivity to insulin. It helps lower blood sugar levels by making cells more responsive to insulin, enhancing glucose uptake in muscle and adipose tissue, and reducing hepatic glucose production.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nBenefits of PIOSTERIS M 500\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: Pioglitazone helps improve the body's response to insulin, while Metformin enhances insulin sensitivity and reduces hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PIOSTERIS M 500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PIOSTERIS M 500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nLipid Profile Improvement: Pioglitazone has been shown to improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, which can provide additional cardiovascular benefits.\nSustained Blood Sugar Control: The sustained-release formulation of Metformin ensures prolonged blood sugar control throughout the day, improving patient compliance and overall effectiveness.\nHow to Use PIOSTERIS M 500\nDosage and Administration\nRecommended Dosage: The typical dosage of PIOSTERIS M 500 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PIOSTERIS M 500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/piosteris-m-500-134243", "price": 118.0, "discountamount": 35.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "TZD", "day", "body", "Diet", "meals", "EMAIL", "cells", "water", "Order", "liver", "amount", "action", "muscle", "Support", "Overview", "readings", "patients", "biguanide", "one tablet", "full glass", "neuropathy", "Guidelines", "utilization", "retinopathy", "PIOSTERIS M", "Adjustments", "information", "Optimal Use", "Introduction", "best results", "Reduced Risk", "Pioglitazone", "sterisonline", "sterispharma", "CALL/WHATSAPP", "triglycerides", "Consistent Use", "treatment plan", "dual mechanism", "typical dosage", "adipose tissue", "lipid profiles", "Administration", "two medications", "Exercise Adjunct", "prolonged effect", "excellent adjunct", "multiple pathways", "thiazolidinedione", "glucose regulation", "Recommended Dosage", "patient compliance", "Insulin Sensitivity", "healthcare provider", "individual response", "Diabetes Management", "overall effectiveness", "HDL cholesterol levels", "cardiovascular disease", "combination medication", "Metformin Hydrochloride", "long-term complications", "lifestyle modifications", "complementary mechanisms", "type 2 diabetes mellitus", "Lipid Profile Improvement", "stable blood sugar levels", "peripheral glucose uptake", "hepatic glucose production", "Additional Health Benefits", "gastrointestinal discomfort", "sustained-release formulation", "prolonged blood sugar control", "Sustained Blood Sugar Control", "comprehensive glycemic control", "Effective Blood Sugar Management", "additional cardiovascular benefits", "Metformin Sustained Release Tablet", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1411, "imageuri": "https://productimages.withfloats.com/actual/6661621b9a0a3c2c0600b4ca.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661621b9a0a3c2c0600b4ca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T07:15:36.695Z", "updatedon": "2024-06-29T10:21:20.999Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/piosteris-m-500-/1411", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIOSTERIS M 500 ", "category": "DIABETIC RANGE", "tags": [ "PIOSTERIS M 500", "Pioglitazone", "Metformin Sustained Release Tablet", "Metformin hydrochloride 500 mg", "Metformin SR 500 dosage", "Metformin Hydrochloride Tablets IP 500mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661614c870e7b20c49e4e49", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIOSTERIS 7.5 ", "description": "PIOSTERIS 7.5 \nPioglitazone (7.5mg)\nIntroduction to PIOSTERIS 7.5\nPIOSTERIS 7.5 contains Pioglitazone 7.5mg, a medication used primarily for the management of type 2 diabetes mellitus. Pioglitazone belongs to a class of drugs known as thiazolidinediones (TZDs), which help improve blood sugar control by increasing the body's sensitivity to insulin. This medication is typically used in combination with diet and exercise to enhance glycemic control in adults with type 2 diabetes.\n\nWhat is Pioglitazone?\nOverview of Pioglitazone\nPioglitazone is an oral diabetes medication that works by making cells more sensitive to insulin, thereby allowing the body to use insulin more effectively. This helps lower blood sugar levels in patients with type 2 diabetes. Pioglitazone can be used alone or in combination with other antidiabetic medications.\n\nMechanism of Action\nInsulin Sensitization: Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPARγ) receptors, which are involved in the regulation of genes responsible for glucose and lipid metabolism. This activation increases the sensitivity of body tissues to insulin.\nGlucose Uptake: By improving insulin sensitivity, Pioglitazone enhances glucose uptake in muscle and adipose tissue and reduces hepatic glucose production, leading to lower blood sugar levels.\nBenefits of PIOSTERIS 7.5\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: PIOSTERIS 7.5 helps improve the body's response to insulin, leading to better control of blood sugar levels.\nComprehensive Glycemic Control: By targeting insulin resistance, Pioglitazone provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PIOSTERIS 7.5 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PIOSTERIS 7.5 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nLipid Profile Improvement: Pioglitazone has been shown to improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, which can provide additional cardiovascular benefits.\nHow to Use PIOSTERIS 7.5\nDosage and Administration\nRecommended Dosage: The typical dosage of PIOSTERIS 7.5 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PIOSTERIS 7.5 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/piosteris-7-5-133430", "price": 59.0, "discountamount": 17.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "TZDs", "diet", "lower", "cells", "class", "water", "drugs", "EMAIL", "Order", "genes", "adults", "muscle", "Action", "Support", "readings", "Overview", "patients", "same time", "PIOSTERIS", "one tablet", "full glass", "regulation", "activation", "neuropathy", "Guidelines", "retinopathy", "combination", "Consistency", "Adjustments", "information", "Optimal Use", "best results", "Reduced Risk", "sterispharma", "body tissues", "Pioglitazone", "Introduction", "sterisonline", "triglycerides", "CALL/WHATSAPP", "typical dosage", "Administration", "treatment plan", "Consistent Use", "lipid profiles", "adipose tissue", "Glucose Uptake", "Exercise Adjunct", "lipid metabolism", "unique mechanism", "PPARγ) receptors", "excellent adjunct", "insulin resistance", "thiazolidinediones", "Recommended Dosage", "insulin sensitivity", "Diabetes Management", "blood sugar control", "healthcare provider", "individual response", "Insulin Sensitization", "cardiovascular disease", "HDL cholesterol levels", "long-term complications", "lifestyle modifications", "oral diabetes medication", "type 2 diabetes mellitus", "Lipid Profile Improvement", "stable blood sugar levels", "other diabetes medications", "Additional Health Benefits", "hepatic glucose production", "Comprehensive Glycemic Control", "other antidiabetic medications", "Effective Blood Sugar Management", "additional cardiovascular benefits", "comprehensive blood sugar management", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1410, "imageuri": "https://productimages.withfloats.com/actual/6661614f7b1fc3f9dd4c82f7.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661614f7b1fc3f9dd4c82f7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T07:12:12.153Z", "updatedon": "2024-06-29T10:23:25.301Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//piosteris-7-5-/1410", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIOSTERIS 7.5 ", "category": "DIABETIC RANGE", "tags": [ "PIOSTERIS 7.5", "Pioglitazone (7.5mg)", "pioz 7.5 price", "pioz 7.5 side effects", "tab pioz 7.5 uses", "pioz 7.5 tablet 10" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66615f8cccd5ce1a10758f47", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIOSTERIS 30 ", "description": "PIOSTERIS 30 \nPioglitazone (30mg)\nIntroduction to PIOSTERIS 30\nPIOSTERIS 30 contains Pioglitazone 30mg, a medication used primarily for the management of type 2 diabetes mellitus. Pioglitazone belongs to a class of drugs known as thiazolidinediones (TZDs), which help improve blood sugar control by increasing the body's sensitivity to insulin. This medication is typically used in combination with diet and exercise to enhance glycemic control in adults with type 2 diabetes.\n\nWhat is Pioglitazone?\nOverview of Pioglitazone\nPioglitazone is an oral diabetes medicine that works by making cells more sensitive to insulin, thereby allowing the body to use insulin more effectively. This helps lower blood sugar levels in patients with type 2 diabetes. Pioglitazone can be used alone or in combination with other antidiabetic medications.\n\nMechanism of Action\nInsulin Sensitization: Pioglitazone works by activating peroxisome proliferator-activated receptor gamma (PPARγ) receptors, which are involved in the regulation of genes responsible for glucose and lipid metabolism. This activation increases the sensitivity of body tissues to insulin.\nGlucose Uptake: By improving insulin sensitivity, Pioglitazone enhances glucose uptake in muscle and adipose tissue and reduces hepatic glucose production, leading to lower blood sugar levels.\nBenefits of PIOSTERIS 30\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: PIOSTERIS 30 helps improve the body's response to insulin, leading to better control of blood sugar levels.\nComprehensive Glycemic Control: By targeting insulin resistance, Pioglitazone provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PIOSTERIS 30 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PIOSTERIS 30 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nLipid Profile Improvement: Pioglitazone has been shown to improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, which can provide additional cardiovascular benefits.\nHow to Use PIOSTERIS 30\nDosage and Administration\nRecommended Dosage: The typical dosage of PIOSTERIS 30 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PIOSTERIS 30 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/piosteris-30-134190", "price": 95.0, "discountamount": 28.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "TZDs", "diet", "food", "cells", "genes", "water", "Order", "class", "EMAIL", "drugs", "muscle", "adults", "Action", "Support", "readings", "Overview", "patients", "same time", "PIOSTERIS", "full glass", "Guidelines", "neuropathy", "one tablet", "activation", "regulation", "Optimal Use", "combination", "information", "Adjustments", "Consistency", "retinopathy", "sterisonline", "sterispharma", "best results", "Introduction", "Reduced Risk", "body tissues", "CALL/WHATSAPP", "triglycerides", "Administration", "typical dosage", "lipid profiles", "treatment plan", "Consistent Use", "Glucose Uptake", "adipose tissue", "Exercise Adjunct", "PPARγ) receptors", "unique mechanism", "lipid metabolism", "excellent adjunct", "Pioglitazone 30mg", "insulin resistance", "thiazolidinediones", "Recommended Dosage", "insulin sensitivity", "healthcare provider", "Diabetes Management", "individual response", "blood sugar control", "Insulin Sensitization", "cardiovascular disease", "HDL cholesterol levels", "oral diabetes medicine", "lifestyle modifications", "long-term complications", "type 2 diabetes mellitus", "lower blood sugar levels", "stable blood sugar levels", "Lipid Profile Improvement", "other diabetes medications", "Additional Health Benefits", "hepatic glucose production", "Comprehensive Glycemic Control", "other antidiabetic medications", "Effective Blood Sugar Management", "additional cardiovascular benefits", "comprehensive blood sugar management", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1407, "imageuri": "https://productimages.withfloats.com/actual/66615f8f8e77bb2c715607af.png", "tileimageuri": "https://productimages.withfloats.com/tile/66615f8f8e77bb2c715607af.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T07:04:44.526Z", "updatedon": "2024-06-29T10:30:40.061Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//piosteris-30-/1407", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIOSTERIS 30 ", "category": "DIABETIC RANGE", "tags": [ "PIOSTERIS 30", "Pioglitazone (30mg)", "Pioglitazone 30mg uses", "Pioglitazone 30mg side effects", "Pioglitazone dose", "pioglitazone price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }